U.S. Veterans Study: Second Protocol Amendment Submitted to FDA

On September 30, 2010, our clinical team submitted the second protocol amendment for our recently initiated U.S. study of MDMA-assisted psychotherapy for veterans with PTSD to the FDA for review.